382 related articles for article (PubMed ID: 17669852)
1. Gastric fluid bile concentrations and risk of Barrett's esophagus.
Nason KS; Farrow DC; Haigh G; Lee SP; Bronner MP; Rosen SN; Vaughan TL
Interact Cardiovasc Thorac Surg; 2007 Jun; 6(3):304-7. PubMed ID: 17669852
[TBL] [Abstract][Full Text] [Related]
2. Management of Barrett's esophagus free of dysplasia.
DeMeester SR
Semin Thorac Cardiovasc Surg; 1997 Jul; 9(3):279-84. PubMed ID: 9263346
[TBL] [Abstract][Full Text] [Related]
3. Increased acid and bile reflux in Barrett's esophagus compared to reflux esophagitis, and effect of proton pump inhibitor therapy.
Menges M; Müller M; Zeitz M
Am J Gastroenterol; 2001 Feb; 96(2):331-7. PubMed ID: 11232672
[TBL] [Abstract][Full Text] [Related]
4. Fatty acid synthase expression in Barrett's esophagus: implications for carcinogenesis.
Ishimura N; Amano Y; Sanchez-Siles AA; Fukuhara H; Takahashi Y; Uno G; Tamagawa Y; Mishima Y; Yuki T; Ishihara S; Kinoshita Y
J Clin Gastroenterol; 2011 Sep; 45(8):665-72. PubMed ID: 21325951
[TBL] [Abstract][Full Text] [Related]
5. Risk factors, DNA damage, and disease progression in Barrett's esophagus.
Olliver JR; Hardie LJ; Gong Y; Dexter S; Chalmers D; Harris KM; Wild CP
Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):620-5. PubMed ID: 15767340
[TBL] [Abstract][Full Text] [Related]
6. Is Barrett's esophagus characterized by more pronounced acid reflux than severe esophagitis?
Coenraad M; Masclee AA; Straathof JW; Ganesh S; Griffioen G; Lamers CB
Am J Gastroenterol; 1998 Jul; 93(7):1068-72. PubMed ID: 9672332
[TBL] [Abstract][Full Text] [Related]
7. Barrett's esophagus and medications that relax the lower esophageal sphincter.
Corley DA; Levin TR; Habel LA; Buffler PA
Am J Gastroenterol; 2006 May; 101(5):937-44. PubMed ID: 16573773
[TBL] [Abstract][Full Text] [Related]
8. Gastric surgery does not increase the risk of developing Barrett's esophagus.
Parrilla P; Liron R; Martinez de Haro LF; Ortiz A; Molina J; De Andrés B
Am J Gastroenterol; 1997 Jun; 92(6):960-3. PubMed ID: 9177510
[TBL] [Abstract][Full Text] [Related]
9. Barrett's esophagus: a discrepancy between macroscopic and histological diagnosis.
Endlicher E; Rümmele P; Beer S; Knüchel R; Rath H; Schlottmann K; Grossmann J; Woenckhaus U; Schölmerich J; Messmann H
Endoscopy; 2005 Nov; 37(11):1131-5. PubMed ID: 16281145
[TBL] [Abstract][Full Text] [Related]
10. Review article: management of oesophageal adenocarcinoma -- control of acid, bile and inflammation in intervention strategies for Barrett's oesophagus.
Jankowski JA; Anderson M
Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 5():71-80; discussion 95-6. PubMed ID: 15456468
[TBL] [Abstract][Full Text] [Related]
11. [Association between symptomatic gastroesophageal reflux and Barrett's esophagus].
Trujillo-Benavides OE; Baltazar-Montúfar P; Angeles-Garay U; Ramírez-Mendoza P; Navarro-García AM; Paredes-Cruz E; Méndez del Monte R; Guerrero-Hernández M
Rev Gastroenterol Mex; 2005; 70(1):14-9. PubMed ID: 16170957
[TBL] [Abstract][Full Text] [Related]
12. No association between hOGG1, XRCC1, and XPD polymorphisms and risk of reflux esophagitis, Barrett's esophagus, or esophageal adenocarcinoma: results from the factors influencing the Barrett's adenocarcinoma relationship case-control study.
Ferguson HR; Wild CP; Anderson LA; Murphy SJ; Johnston BT; Murray LJ; Watson RG; McGuigan J; Reynolds JV; Hardie LJ
Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):736-9. PubMed ID: 18349297
[TBL] [Abstract][Full Text] [Related]
13. Quantification of duodenogastric reflux in Barrett's esophagus.
Lirón R; Parrilla P; Martinez de Haro LF; Ortiz A; Robles R; Luján JA; Fuente T; Andrés B
Am J Gastroenterol; 1997 Jan; 92(1):32-6. PubMed ID: 8995933
[TBL] [Abstract][Full Text] [Related]
14. Abdominal obesity and body mass index as risk factors for Barrett's esophagus.
Corley DA; Kubo A; Levin TR; Block G; Habel L; Zhao W; Leighton P; Quesenberry C; Rumore GJ; Buffler PA
Gastroenterology; 2007 Jul; 133(1):34-41; quiz 311. PubMed ID: 17631128
[TBL] [Abstract][Full Text] [Related]
15. Bile reflux in columnar-lined Barrett's oesophagus.
Iftikhar SY; Ledingham S; Steele RJ; Evans DF; Lendrum K; Atkinson M; Hardcastle JD
Ann R Coll Surg Engl; 1993 Nov; 75(6):411-6. PubMed ID: 8285543
[TBL] [Abstract][Full Text] [Related]
16. Low incidence of adenocarcinoma and high-grade intraepithelial neoplasia in patients with Barrett's esophagus: a prospective cohort study.
Martinek J; Benes M; Brandtl P; Hucl T; Vasicek M; Voska L; Lanska V; Nosek V; Spicak J
Endoscopy; 2008 Sep; 40(9):711-6. PubMed ID: 18698534
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of and risk factors for Barrett's esophagus with intestinal predominant mucin phenotype.
Amano Y; Kushiyama Y; Yuki T; Takahashi Y; Moriyama I; Fukuhara H; Ishimura N; Furuta K; Ishihara S; Adachi K; Maruyama R; Kinoshita Y
Scand J Gastroenterol; 2006 Aug; 41(8):873-9. PubMed ID: 16803684
[TBL] [Abstract][Full Text] [Related]
18. Expression of the bile acid receptor FXR in Barrett's esophagus and enhancement of apoptosis by guggulsterone in vitro.
De Gottardi A; Dumonceau JM; Bruttin F; Vonlaufen A; Morard I; Spahr L; Rubbia-Brandt L; Frossard JL; Dinjens WN; Rabinovitch PS; Hadengue A
Mol Cancer; 2006 Oct; 5():48. PubMed ID: 17054793
[TBL] [Abstract][Full Text] [Related]
19. Cyclooxygenase-2 and inducible nitric oxide synthase gene polymorphisms and risk of reflux esophagitis, Barrett's esophagus, and esophageal adenocarcinoma.
Ferguson HR; Wild CP; Anderson LA; Murphy SJ; Johnston BT; Murray LJ; Watson RG; McGuigan J; Reynolds JV; Hardie LJ
Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):727-31. PubMed ID: 18349295
[TBL] [Abstract][Full Text] [Related]
20. Barrett's esophagus in females: a comparative analysis of risk factors in females and males.
Banki F; Demeester SR; Mason RJ; Campos G; Hagen JA; Peters JH; Bremner CG; Demeester TR
Am J Gastroenterol; 2005 Mar; 100(3):560-7. PubMed ID: 15743352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]